colonsentryI think the question that needs to be answered is, why has the company been unable to market Colonsentry. I have emailed this question to jht but have had no response as yet. For what ever the reason is, it certanly has to be corrected if we are to expect a profitable level of sales from Aristotle. $130,000 in sales for two type of cancer translates to less than $1,000,000 for 10